Tranilast: Completed Phase III trial enrollment

SmithKline Beecham plc (LSE:SB; SBH), London, U.K. Product: Tranilast Business: Cardiovascular Therapeutic category: Cell proliferation Target: Smooth muscle cells and inflammation mediators Descript...